2007
DOI: 10.1016/j.brainresbull.2007.01.011
|View full text |Cite
|
Sign up to set email alerts
|

The effect of sevoflurane on the release of [3H]dopamine from rat brain cortical slices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 34 publications
0
7
0
Order By: Relevance
“…Research on these proteins has revealed that γ‐aminobutyric acid type A (GABA A ) receptors are likely involved in the molecular actions of sevoflurane (11–17). It may also act by inhibiting excitatory ion channels such as neuronal nicotinic and glutamate receptors (12, 18–22). The action of a volatile agent on neurotransmitter receptors is dominant, while it also affects the release of neurotransmitters.…”
mentioning
confidence: 99%
“…Research on these proteins has revealed that γ‐aminobutyric acid type A (GABA A ) receptors are likely involved in the molecular actions of sevoflurane (11–17). It may also act by inhibiting excitatory ion channels such as neuronal nicotinic and glutamate receptors (12, 18–22). The action of a volatile agent on neurotransmitter receptors is dominant, while it also affects the release of neurotransmitters.…”
mentioning
confidence: 99%
“…9 Regarding the presynaptic effects of these anesthetics, isoflurane and halothane increase basal dopamine release in the rat striatum. 26 In addition, although Silva and colleagues 27 have shown that sevoflurane (0.46 mM) increases significantly the release of dopamine, it was by a nonvesicular process independent of synaptic vesicle exocytosis. Moreover, Shichino et al 28 showed that volatile anesthetics such as sevoflurane and isoflurane suppressed ACh release in a dose-dependent manner in nonstimulated rat cerebral cortex.…”
Section: Discussionmentioning
confidence: 97%
“…Sevoflurane also has many biochemical actions, and it has been shown to inhibit the function of the nicotinic acetylcholine receptor in the postsynaptic membrane and significantly reduce the transmission of acetylcholine between synapses ( 55 ). Nishikawa et al found that sevoflurane enhanced GABAA receptor-mediated synaptic inhibition in hippocampal interneurons ( 56 ), and Silva JH et al found that sevoflurane increased the levels of extracellular [3H] dopamine in rat brain cortical slices ( 57 ). The effects of propofol and sevoflurane on neurotransmitters in the central nervous system are related to the neural mechanism of the attention network, which can reduce the efficiency of the attention network.…”
Section: Discussionmentioning
confidence: 99%